spirogermanium has been researched along with Ovarian Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajani, JA; Bodey, GP; Legha, SS | 1 |
| Brenner, DE; Burnett, L; Dillon, M; Forastiere, A; Greco, FA; Grumbine, F; Jones, HW; Rosenshein, NB; Tipping, S; Wiernik, PH | 1 |
| Budman, DR; Degnan, TJ; Pasmantier, M; Schulman, P; Vinciguerra, V; Weiselberg, L | 1 |
| Goodman, S | 1 |
| Copeland, LJ; Gershenson, DM; Kavanagh, JJ; Krakoff, IH; Saul, PB | 1 |
1 trial(s) available for spirogermanium and Ovarian Neoplasms
| Article | Year |
|---|---|
Therapeutic effects of organic germanium.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antineoplastic Agents; Arthritis; Clinical Trials as Topic; Female; Germanium; Humans; Leukemia, Experimental; Lung Neoplasms; Lymphoproliferative Disorders; Malaria; Organometallic Compounds; Osteoporosis; Ovarian Neoplasms; Spiro Compounds | 1988 |
4 other study(ies) available for spirogermanium and Ovarian Neoplasms
| Article | Year |
|---|---|
Phase I study of spirogermanium given daily.
Topics: Adult; Aged; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Germanium; Humans; Infusions, Parenteral; Lymphoma; Male; Middle Aged; Nausea; Nervous System Diseases; Organometallic Compounds; Ovarian Neoplasms; Spiro Compounds | 1983 |
Phase II evaluation of spirogermanium in advanced ovarian carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Germanium; Humans; Middle Aged; Organometallic Compounds; Ovarian Neoplasms; Spiro Compounds | 1983 |
Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Female; Germanium; Humans; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Ovarian Neoplasms; Spiro Compounds | 1982 |
Continuous-infusion spirogermanium for the treatment of refractory carcinoma of the ovary: a phase II trial.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Germanium; Humans; Infusions, Parenteral; Middle Aged; Organometallic Compounds; Ovarian Neoplasms; Spiro Compounds | 1985 |